Connective Tissue Diseases and Lung Manifestations

Launched by MEDICAL UNIVERSITY INNSBRUCK · Sep 18, 2019

Keywords

ClinConnect Summary

This clinical trial, titled "Connective Tissue Diseases and Lung Manifestations," is focused on understanding how lung diseases, specifically interstitial lung disease (ILD) and pulmonary hypertension (PH), affect patients with connective tissue diseases (CTD). The goal is to gather detailed information about how common these lung issues are, how they progress, and the best ways to manage them in real-life situations. Researchers are particularly interested in identifying patients whose condition is getting worse, the best timing to start treatment, and what might be causing these lung problems.

To participate in this study, individuals must be at least 18 years old and have been diagnosed with a connective tissue disease. They will not be eligible if they have other serious health issues that could interfere with the study. Participants will be involved in a registry, meaning their health information will be collected over time to help researchers learn more about the impacts of ILD and PH in patients with CTD. This information could help improve understanding and treatment options for these conditions in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • The inclusion criteria are adult patients (≥18 years) diagnosed with CTD with signed informed consent.
• Exclusion Criteria:
• • Exclusion criteria are patients with a serious co-morbidity interfering with the course of interstitial lung disease or pulmonary hypertension.